first-in-human study

ENCINITAS, California, USA & WROCLAW, Poland – June 8, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies...

SAN CARLOS, Calif., June 2, 2026 Vaxcyte, Inc. announced that the first participant has been dosed in a Phase...

MINNEAPOLIS, Minnesota — December 15, 2025 — Medical 21, Inc., a privately held medical technology company, announced it has...